These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 15388824

  • 1. Development of transplant renal artery thrombosis and signs of haemolytic-uraemic syndrome following the change from cyclosporin to tacrolimus in a renal transplant patient.
    Kiykim AA, Ozer C, Yildiz A, Tiftik N, Senli M, Kelebek E, Doruk E, Akbay E.
    Nephrol Dial Transplant; 2004 Oct; 19(10):2653-6. PubMed ID: 15388824
    [No Abstract] [Full Text] [Related]

  • 2. Conversion of renal transplant recipients from cyclosporin (neoral) to tacrolimus (prograf) for haemolytic uraemic syndrome.
    Morris-Stiff G, Talbot D, Balaji V, Baboolal K, Callanan K, Hails J, Moore R, Manas D, Lord R, Jurewicz WA.
    Transpl Int; 1998 Oct; 11 Suppl 1():S98-9. PubMed ID: 9664954
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The successful conversion to Tacrolimus (FK506) of a renal transplant recipient with cyclosporin-induced haemolytic-uraemic syndrome.
    Richardson D, Jones CH, Newstead CG, Will EJ, Lodge JP.
    Nephrol Dial Transplant; 1996 Dec; 11(12):2498-500. PubMed ID: 9017633
    [No Abstract] [Full Text] [Related]

  • 8. Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus.
    Pratap B, Abraham G, Srinivas CN, Bhaskar S.
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):609-12. PubMed ID: 17951952
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Uneventful re-treatment with cyclosporin in two cases of cyclosporin-induced haemolytic uraemic syndrome.
    Guella A, Daoud M, Al Dayel A.
    Nephrol Dial Transplant; 1998 Jul; 13(7):1864-5. PubMed ID: 9681750
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
    Wiener Y, Nakhleh RE, Lee MW, Escobar FS, Venkat KK, Kupin WL, Mozes MF.
    Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
    Furlong T, Storb R, Anasetti C, Appelbaum FR, Deeg HJ, Doney K, Martin P, Sullivan K, Witherspoon R, Nash RA.
    Bone Marrow Transplant; 2000 Nov; 26(9):985-91. PubMed ID: 11100278
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Haemolytic uraemic syndrome during cyclosporin therapy for Behcet's disease.
    Chatterjee A, D'Souza RJ.
    Nephrol Dial Transplant; 1997 Dec; 12(12):2799-800. PubMed ID: 9430907
    [No Abstract] [Full Text] [Related]

  • 20. Effect of cyclosporin A and tacrolimus on sister chromatid exchange frequency in renal transplant patients.
    Oztürk S, Ayna TK, Cefle K, Palanduz S, Ciftçi HS, Kaya SA, Diler AS, Türkmen A, Gürtekin M, Sever MS, Carin M.
    Genet Test; 2008 Sep; 12(3):427-30. PubMed ID: 18752452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.